Sites
Tags
- Aciclovir
- Adenine
- American Society of Health-System Pharmacists
- Antiviral drug
- ATC code S01
- Bioavailability
- Biological half-life
- Board of directors
- Brincidofovir
- Brivudine
- CAS Registry Number
- ChEMBL
- Chemical formula
- Cherrington
- Clinical trial
- Cytarabine
- Cytosine
- Czech Academy of Sciences
- DNA virus
- Docosanol
- DOI
- Drug
- DrugBank
- Drug development
- Drug nomenclature
- Early protein
- Efavirenz/emtricitabine/tenofovir
- Effect
- Emtricitabine/tenofovir
- Entecavir
- European Chemicals Agency
- Excretion
- Famciclovir
- Food and Drug Administration
- Ganciclovir
- Gilead Sciences
- Guanine
- Hepatitis B
- Herpesviridae
- HIV
- Human papillomavirus infection
- Imiquimod
- Interferon
- Interferon alfa-2b
- International Chemical Identifier
- Jmol
- Julie Cherrington
- KEGG
- Lamivudine
- Lawsuit
- Letermovir
- Management of HIV/AIDS
- Maribavir
- Molar mass
- Nucleoside analogue
- Oncology
- Over
- Penciclovir
- Pharmacokinetics
- Phases of clinical research
- Pivaloyloxymethyl
- Plasma protein binding
- Podophyllotoxin
- Poxviridae
- Prescription drug
- Prodrug
- PubChem
- PubMed
- Regulation of therapeutic goods
- Reverse transcriptase
- Reverse-transcriptase inhibitor
- Ribavirin
- Rifampicin
- Route of administration
- Standard for the Uniform Scheduling of Medicines and Poisons
- TDF
- Tecovirimat
- Tenofovir alafenamide
- Tenofovir disoproxil
- Thymine
- Toxic
- Transaminase
- Trifluridine
- Trifluridine/tipiracil
- Uridine
- Vaccinia
- Valaciclovir
- Valganciclovir
- WHO Model List of Essential Medicines